🇺🇸 FDA
Patent

US 12071477

Anti-folate receptor alpha antibody conjugated with hemiasterlins

granted A61KA61K31/537A61K31/5545

Quick answer

US patent 12071477 (Anti-folate receptor alpha antibody conjugated with hemiasterlins) held by Sutro Biopharma, Inc. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sutro Biopharma, Inc.
Grant date
Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/537, A61K31/5545, A61K38/06, A61K38/08